Founded in 2024 out of the Italian Institute of Technology, Generative Bionics designs and manufactures humanoid robots that combine advanced robotics, tactile and force-sensing networks, and a proprietary Physical AI architecture. Its robots are engineered for hazardous, repetitive, and high-intensity tasks across manufacturing, logistics, healthcare, and retail settings. The company is integrating roughly 70 IIT engineers and specialists in certification, industrialization, and production to accelerate product development. Proceeds from its recent funding will finance industrial validation, the build-out of its first production plant, and completion of initial deployment contracts targeted for public announcement in early 2026. Generative Bionics’ first fully integrated humanoid model is slated to debut internationally at CES in Las Vegas. Long-term, management aims to position the firm as a global leader in the humanoid robotics market, which analysts project could exceed €200 billion by 2035 and $5 trillion by 2050. The company leverages IP from IIT projects such as iCub, ergoCub, and iRonCub, granting it exclusive licenses to several core technologies developed in collaboration with INAIL under the Physical AI program.

Total raised

$82M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2025